Valerio Therapeutics's total assets for Q4 2025 were €15.23M, a decrease of -15.03% from the previous quarter. FR:ALVIO total liabilities were €13.16M for the fiscal quarter, a -49.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.